Alaunos Therapeutics (TCRT) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Michael Wong resigned as Vice President, Finance of Alaunos Therapeutics, and Ferdinand Groenewald has been appointed in his stead through a consulting agreement effective immediately. Groenewald, a seasoned finance professional and CPA with extensive experience in various financial roles, will lead the company’s accounting and financial reporting for $15,000 per month plus expenses. His term is indefinite, with a 30-day termination notice by either party, and includes customary officer indemnification provisions. Groenewald’s prior roles include leadership positions at Muscle Maker, Inc., and board memberships at several Nasdaq-listed companies.
For further insights into TCRT stock, check out TipRanks’ Stock Analysis page.
